Multimodal optical imaging platform for the early diagnosis for oral neoplasia

Conference Dates

July 23-26, 2017


Early diagnosis is critical to reducing the global burden of oral cancer. In the US, 65% of oral cancer patients are diagnosed after regional metastasis; these patients have a 50% five-year mortality compared to 17% for those with localized disease. A major reason for late diagnosis is that clinicians are unable to accurately distinguish neoplastic lesions, which require treatment, from benign lesions. Furthermore, clinicians are unable to accurately select to biopsy the site with the worst diagnosis within a larger lesion.

Please download the file below for full content.

40.pdf (123 kB)

This document is currently not available here.